|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers显示文摘AIM: To elucidate the differences in somatic, psycho-logical and biochemical pattern between the subtypes of irritable bowel syndrome (IBS). METHODS: Eighty IBS patients, 30 diarrhoea pre-dominant (D-IBS), 16 constipation predominant (C-IBS) and 34 alternating IBS (A-IBS) underwent physi-otherapeutic examinations for dysfunctions in body movements and awareness and were compared to an apparently healthy control group (AHC). All groups an-swered questionnaires for gastrointestinal and psycho-logical symptoms. Biochemical variables were analysed in blood. RESULTS: The D-IBS group showed less body aware-ness, less psychological symptoms, a more normal sense of coherence and psychosocial rating as well as higher C-peptide values. C-IBS had a higher degree of body dysfunction and psychological symptoms, as well as the lowest sense of coherence compared to controls and D-IBS. They also demonstrated the most elevated prolactin levels. A-IBS had the lowest degree of body disturbance, deteriorated quality of life and affected bi-ochemical pattern. All subtypes had higher pain scores compared to controls. In addition they all had signifi -cantly increased triglycerides and elevated morning cortisol levels, however, without statistical signifi cance compared with the controls.CONCLUSION: IBS subtypes showed different pro-files in body awareness, somatic and psychological symptoms and in biochemical variables. D-IBS differed compared to the other groups by lowered body aware-ness, less psychological symptoms and a higher sense of coherence and elevated C-peptide values. C-IBS and A-IBS subtypes suffered more from depression and anxiety, associated with a lower quality of life. These differences may be important and will be taken into account in our treatment of these patients. | Elsa M Eriksson Kristina I Andrén Henry T Eriksson Gran K Kurlberg | 2008 | World Journal of Gastroenterology2008，14，31： | 7 |
| 2 | Effects of terbuthylazine on soil fauna and decomposition processes 显示文摘 | Salminen J Eriksson I Haimi J | 1996 | Ecotoxicology and Environmental Safety1996，34，2： | 1 |
| 3 | Proteome analysis of conditioned medium from cultured adult hippocampal progenitors显示文摘 | Dahl A Eriksson P S Persson A I Karlsson G Davidsson P Ekman R | | 0，，： | 1 |
| 4 | Pharmacoki- netics of thalidomide in patients with impaired renal function and while on and off dialysis 显示文摘 | Eriksson T Hoglund P Turesson I | 2003 | J Pharm Pharmacol2003，55，： | 1 |
| 5 | Pre-operativefasting guidelines:an update显示文摘 | Soreide E Eriksson L I Hirlekar G | 2005 | Acta Anaesthesiol Scand2005，49，8： | 1 |
| 6 | Sedation for fibreoptic gastroscopy:a comparative study of midazolem and diazepam显示文摘 | Berggren L Eriksson I Mollenholt P | 1985 | Br J Anaesth1985，55，4： | 1 |
| 7 | Refractory generalised convulsive status epilepticus: a guide to treatment 显示文摘 | Kalviainen R Eriksson K Parvisinen I | 2005 | CNS Drugs2005，19，9： | 1 |
| 8 | The barrow neurological institute screen for higher cerebral functions in cognitive screening after stroke显示文摘 | Redfors P Hofgren C Eriksson I | 2014 | Journal of stroke and cerebrovascular diseases:the official journal of National Stroke Association2014，23，2： | 1 |
| 9 | Femoral-artery infusion of prostaglandin E1 in severe peripheral vascular disease显示文摘 | Eriksson I | 1973 | Lancet1973，1，： | 1 |
| 10 | Vasoactive agents and blood pressure regulation in sequential ultrafiltration and hemodialysis 显示文摘 | Odar-Cederlof I Theodorsson E Eriksson CG | 1993 | Int J Artif Organs1993，16，9： | 1 |
| 11 | Pharmacokinetics of Thalidomide in Patients with Impaired Renal Function and While on and off Dialysis显示文摘 | Eriksson T Hoglund P Turesson I | 2003 | Journal of Pharmacy and Pharmacology2003，55，： | 1 |
| 12 | Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial显示文摘 | Ajay K Kakkar Benjamin Brenner Ola E Dahl Bengt I Eriksson Patrick Mouret Jim Muntz Andrea G Soglian ákos F Pap Frank Misselwitz Sylvia Haas | 2008 | The Lancet2008，，9632： | 1 |
| 13 | Visual field constriction in 91 Finnish children treated with vigabatrin显示文摘 | Vanhatalo S Nousiainen I Eriksson K | | 0，，07： | 1 |
| 14 | Oral dabigatran ver- sus enoxaparin for thromboprophylaxis after primary total hip arthre- plasty ( RE-NOVATEII * )显示文摘 | ERIKSSON B I DAHL O E HUO M H | 2011 | Thromb Haemost2011，105，4： | 1 |
| 15 | Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis显示文摘 | Dellgren G Eriksson MJ Blange I | 1999 | The American Journal of Cardiology1999，84，： | 1 |
| 16 | Analysis of food proteins for verification of contamination or mislabelling显示文摘 | YMAN I M ERIKSSON A EVERITT G | 1994 | Food and Agricultnral Immunology1994，6，2： | 1 |
| 17 | Single-shot intrathecal sufentanil with bupivacaine in late labour-analgesic quality and obstetric outcome显示文摘 | Eriksson SL Blomberg I Olofsson C | 2003 | Eur J Obstet Gynecol Reprod Biol2003，110，2： | 1 |
| 18 | Genetic a- nalysis reveals that C19-GA 2-oxidation is a major gib- berellin inactivation pathway in Arabidopsis 显示文摘 | RIEU I ERIKSSON S POWERS S J | 2008 | Plant Cell2008，20，9： | 1 |
| 19 | Alpha (2)-HeremansSchmid glycoprotein gene polymorphisms are associated with adipocyte insulin action显示文摘 | Dahlman I Eriksson P Kaaman M | 2004 | Diabetologia2004，47，11： | 1 |
| 20 | A once-daily,oral,direct Factor Xa inhibitor,rivaroxaban(BAY 59-7939),for thromboprophylaxis 显示文摘 | Eriksson B I Borris L C Dahl O E | 2006 | Circulation2006，，22： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员